Effects of thrombin inhibitor on thrombin-related signal transduction and cerebral vasospasm in the rabbit subarachnoid hemorrhage model

Stroke

Volumn 34, Issue 6, 2003, Pages 1497-1500

  Tsurutani, Hisanobu ^a   Ohkuma, Hiroki ^b   Suzuki, Shigeharu ^b  

^a HIROSAKI UNIVERSITY   (Japan)

^b NONE

Author keywords

Rabbits; Subarachnoid hemorrhage; Thrombin; Vasospasm

Indexed keywords

ARGATROBAN; THROMBIN INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASILAR ARTERY; BRAIN ARTERY ANEURYSM; BRAIN VASOSPASM; CISTERNA MAGNA; CONTROLLED STUDY; DRUG EFFECT; ENZYME PHOSPHORYLATION; NONHUMAN; PHOTOMETRY; PRIORITY JOURNAL; PROTHROMBIN TIME; RABBIT; SIGNAL TRANSDUCTION; SUBARACHNOID HEMORRHAGE; VASOCONSTRICTION;

ANIMALS; ANTITHROMBIN III; BASILAR ARTERY; DISEASE MODELS, ANIMAL; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; INJECTIONS, INTRAVENTRICULAR; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; RABBITS; SERINE PROTEINASE INHIBITORS; SIGNAL TRANSDUCTION; SUBARACHNOID HEMORRHAGE; THROMBIN; VASCULAR PATENCY; VASOCONSTRICTION; VASOSPASM, INTRACRANIAL;

EID: 0038313095     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000070424.38138.30     Document Type: Article

References (19)

1. Kassell NF, Helm G, Simmons N, Phillips CD, Cail WS. Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg. 1992;77:848-852.
2. Solomon RA, Antunes JL, Chen RY, Bland L, Chien S. Decrease in cerebral blood flow in rats after experimental subarachnoid hemorrhage: a new animal model. Stroke. 1985;16:58-64.
3. Zubkov AY, Ogihara K, Tumu P, Patlolla A, Lewis AI, Parent AD, Zhang J. Mitogen-activated protein kinase mediation of hemolysate-induced contraction in rabbit basilar artery. J Neurosurg. 1999;90:1091-1097.
4. Suzuki M, Kudo A, Otawara Y, Hirashima Y, Takaku A, Ogawa A. Extrinsic pathway of blood coagulation and thrombin in the cerebral fluid after subarachnoid hemorrhage. Neurosurgery. 1999;44:487-489.
5. Zhang Z, Nagata I, Kikuchi H, Xue JH, Sakai N, Sakai H, Yanamoto H. Broad-spectrum and selective serine protease inhibitors prevent expression of platelet-derived growth factor-BB and cerebral vasospasm after subarachnoid hemorrhage: vasospasm caused by cisternal injection of recombinant platelet-derived growth factor-BB. Stroke. 2001;32:1665-1672.
6. Jerius H, Beall A, Woodrum D, Epstein A, Brophy C. Thrombin-induced vasospasm: cellular signaling mechanisms. Surgery. 1998;123:46-50.
7. Megyesi JF, Vollrath B, Cook DA, Findlay JM. In vivo animal models of cerebral vasospasm: a review. Neurosurgery. 2000;46:448-460.
8. Baker KF, Zervas NT, Pile-Spellman J, Vacanti FX, Miller D. Angiographic evidence of basilar artery constriction in the rabbit: a new model of vasospasm. Surg Neurol. 1987:27:107-112.
9. Vollmer DG, Hongo K, Kassell NF, Ogawa H, Tsukahara T, Lehman RM. Effect of intracistemal antithrombin III on subarachnoid hemorrhage-induced arterial narrowing. J Neurosurg. 1989;70:599-604.
10. Suzuki M, Kudo A, Otawara Y, Doi M, Kuroda K, Ogawa A. Fibrinolytic activity in the CSF and blood following subarachnoid haemorrhage. Acta Neurochir (Wien). 1997;139:1152-1154.
11. Smirnova IV, Salazar A, Arnold PM, Glatt S, Handler M, Festoff BW. Thrombin and its precursor in human cerebrospinal fluid. Thromb Haemost. 1997;78:1473-1479.
12. Suzuki M, Ogawa A, Sakurai Y, Nishino A, Venohara K, Mizoi K, Yoshimoto T. Thrombin activity in cerebrospinal fluid after subarachnoid hemorrhage. Stroke. 1992;23:1181-1182.
13. Peltonen S, Juvela S, Kaste M, Lassila R. Hemostasis and fibrinolysis activation after subarachnoid hemorrhage. J Neurosurg. 1997;87:207-214.
14. Hirashima Y, Nakamura S, Suzuki M, Kurimoto M, Endo S, Ogawa A, Takaku A. Cerebrospinal fluid tissue factor and thrombin-antithrombin III complex as indicators of tissue injury after subarachnoid hemorrhage. Stroke. 1997;28:1666-1670.
15. Kasuya H, Shimizu T, Takakura K. Thrombin activity in CSF after SAH is correlated with the degree of SAH, the persistence of subarachnoid clot and the development of vasospasm. Acta Neurochir (Wien). 1998;140:579-584.
16. Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Koike T, Tanaka R. Serial changes of hemostasis in aneurysmal subarachnoid hemorrhage with special reference to delayed ischemic neurological deficits. J Neurosurg. 1997;86:594-602.
17. Earley JJ, Su X, Moreland RS. Caldesmon inhibits active crossbridges in unstimulated vascular smooth muscle: an antisense oligodeoxynucleotide approach. Circ Res. 1993;83:661-666.
18. Berk BC, Corson MA. Angiotensin signal transduction in vascular smooth muscle: role of tyrosine kinase. Circ Res. 1997;80:607-616.
19. Gabay L, Seger R, Shilo BZ. In situ activation pattern of Drosophila EGF receptor pathway during development. Science. 1997;277:1103-1106.